Skip to main navigation Skip to search Skip to main content

A compound heterozygous missense mutation and a large deletion in the KCTD7 gene presenting as an opsoclonus-myoclonus ataxia-like syndrome

  • Edith Wolfson Medical Center Israel
  • Tel Aviv University
  • Pronto Diagnostics Ltd.

Research output: Contribution to journalArticlepeer-review

52 Scopus citations

Abstract

Mutations in the potassium channel-related gene KCTD7 were described so far in a single family with progressive myoclonus epilepsy. We describe a unique phenotype: acute onset of myoclonus and ataxia, associated with abnormal opsoclonus-like eye movements; improvement of clinical symptoms under steroid treatment; and appearance of epileptic activity on EEG 2 years later without overt seizures. After excluding possible genetic causes, whole-genome exome sequencing was performed in order to identify the causative gene. One heterozygous missense mutation (R84W) was detected by exome sequencing and a large heterozygous deletion of exons 3 and 4 by MLPA analysis. The father is heterozygous for the R84W mutation and the mother is heterozygous for the exon 3+4 deletion. The mutation affects a highly conserved segment of the predicted protein, changing a basic amino acid into neutral. The large deletion probably results in a truncated protein. The different phenotype broadens the spectrum of KCTD7-related diseases. Therefore, patients diagnosed as having opsoclonus-myoclonus with an atypical course should be evaluated for KCTD7 mutations.

Original languageEnglish
Pages (from-to)2590-2598
Number of pages9
JournalJournal of Neurology
Volume259
Issue number12
DOIs
StatePublished - Dec 2012
Externally publishedYes

Keywords

  • Corticosteroid treatment
  • Exomics
  • KCTD7
  • Opsoclonus-myoclonus-Ataxia

Fingerprint

Dive into the research topics of 'A compound heterozygous missense mutation and a large deletion in the KCTD7 gene presenting as an opsoclonus-myoclonus ataxia-like syndrome'. Together they form a unique fingerprint.

Cite this